Objectives:

  1. Discuss the role of neoadjuvant chemotherapy and radiation in rectal cancer treatment
  2. Discuss the optimal surgical strategy for rectal cancer treatment
  3. Discuss the opportunity for active surveillance and organ preservation in rectal cancer treatment
Session date: 
04/01/2026 - 7:30am to 8:30am CDT
Location: 
Hybrid (In-person and Virtual)
United States
See map: Google Maps
  • 1.00 AAPA Category 1 CME
  • 1.00 ABS Accredited CME
    • 1.00 ABS Self-Assessment
  • 1.00 MOC: ABS Lifelong Learning & Self-Assessment Points (Part II)
    This activity meets the ABS requirements for CME and self‐assessment credit toward Part 2 of the ABS MOC program.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™
Add to calendar: 
Please login or register to take this course.
Discloser List CME Internal Report
Presenter(s): 
Martin Weiser, MD